School of Medicine
Showing 1-54 of 54 Results
-
Souradeep Dey
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Souradeep Dey is a postdoctoral scholar at the Stanford Cardiovascular Institute, specializing in tissue engineering, regenerative medicine, organ-on-chip technologies, 3D bioprinting and stem cells. Dr. Dey earned his Ph.D. in Nanotechnology from the Indian Institute of Technology Guwahati, India, where his doctoral research focused on developing clinically relevant 3D printed in vitro microphysiological models for disease modeling and drug screening applications.
-
Ramzi Emanuel Dudum
Member (Postdoc), Cardiovascular Institute
BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health. -
Hiroyuki Inoue
Postdoctoral Scholar, Cardiovascular Institute
BioPhysician-scientist and board-certified cardiologist with expertise in cardiovascular disease, gene therapy, iPSC disease modeling, genome editing, high-throughput screening, and computational approaches for functional genomics and phenotypic data analysis.
Performed 400+ percutaneous coronary interventions (PCI), catheter ablations, and cardiac device implantations as primary operator, and currently conduct translational cardiovascular research at Stanford. -
Nerea Jimenez Tellez
Postdoctoral Scholar, Cardiovascular Institute
BioNerea is a Postdoctoral Scholar at Dr. Joseph Wu's lab. She earned her Bachelor's degree in Biochemistry at Universidad Complutense de Madrid (Spain). She was in an exchange program at the University of Saskatchewan (Canada) where she completed her Honours Thesis project on the Regulation of the Metastasis Suppressor Protein CREB3L1 in Dr. Deborah H Anderson's lab. She received her Masters' degree at Universidad de Alcalá (Spain) working at Dr. Isabel Liste Noya's lab on The role of p27Kip1 in the pluripotency and differentiation of dopaminergic neurons. She obtained her Ph.D. in Dr. Naweed Syed's lab studying the Cellular and molecular mechanisms underlying anesthetic-induced cytotoxicity, and their impact on learning and memory. She has received an ATRAC postdoctoral fellowship (Aug 2022 - Aug 2023), an AHA postdoctoral fellowship (Apr 2023 - Sept 2024) and currently holds a TRDRP Postdoctoral Fellowship (Jul 2024 - Jun 2027) titled "Using a human in vitro platform to study the effects of cannabinoids on the cardiovascular system" .
-
Jiawei Li
Postdoctoral Scholar, Cardiovascular Institute
BioMy research interests include organoids, engineering, and AI.
-
Thulaj Dattatraya Meharwade
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Thulaj Meharwade is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in Inflammaging, disease modeling, cellular heterogeneity and drug discovery. Dr. Meharwade received his PhD in Biochemistry from the University of Montreal, after conducting thesis work on signalling and transcriptional mechanisms regulating cell fate heterogeneity and totipotent stem cells.
-
Debarun Patra
Postdoctoral Scholar, Cardiovascular Institute
BioDebarun Patra is a postdoctoral researcher at Stanford Medicine, with a background in inflammation research. His research focuses on metabolic disease modeling and identifying novel therapeutic targets. His current work integrates inflammatory and metabolic diseases (IBD, MASH, and diabetes), using patient-derived iPS cells and primary cells, and employs advanced multi-omics.
-
Mojtaba Sedigh Fazli
Visiting Instructor/Lecturer, Cardiovascular Institute
Postdoctoral Scholar, Cardiovascular InstituteBioDr. Mojtaba Fazli is a leading scientist specializing in AI/ML, computer vision, and biomedical research. He is currently a Postdoctoral Research fellow Scientist at Stanford University and a Senior Research Fellow at the Harvard Ophthalmology Artificial Intelligence Lab, Harvard University, where he previously completed a postdoctoral fellowship.
Dr. Fazli's research bridges cutting-edge artificial intelligence with groundbreaking applications in multi-scale biomedical imaging, disease modeling, and drug discovery. His expertise encompasses advanced areas of AI/ML, including computer vision for 2D/3D medical image analysis, bioinformatics, and object tracking in both 2D and 3D environments. He has played a key role in developing state-of-the-art algorithms to enhance diagnostic precision and therapeutic outcomes within the biotechnology and healthcare sectors.
With a strong foundation in both academia and industry, Dr. Fazli previously served as a Senior Open Innovation Scholar at the Novartis Institute for Biomedical Research. There, he applied his expertise in strategic planning, programming, and simulation to tackle complex biomedical challenges.
Dr. Fazli holds a Ph.D. in Computer Science, with a minor in Mathematics, from the United States, as well as a Doctorate in Business Administration from France. His academic journey also includes master’s degrees in Economics and Management, as well as Artificial Intelligence and Robotics. His interdisciplinary approach blends AI-driven innovation with practical, impactful solutions in healthcare.
At Stanford, Dr. Fazli leads research initiatives focused on integrating multimodal data in rheumatology, advancing ultrasound imaging research in Rheumatoid Arthritis, and developing AI methodologies for clinical applications. His current work also involves leveraging Generative AI and Large Language Models (LLMs) to drive innovation in medical data analysis and clinical decision support. -
Han Sun
Postdoctoral Scholar, Genetics
Biostatistician 2, Pediatrics - EndocrinologyBioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.
After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes. -
Kristina Zdantsevich
Postdoctoral Scholar, Cardiovascular Institute
BioKristina Zdantsevich, MD, is a physician-scientist and postdoctoral fellow in Joseph Wu's laboratory at the Stanford Cardiovascular Institute, where she uses induced pluripotent stem cells to model cardiovascular disease.
Kristina earned her MD from Belarusian State Medical University, graduating top of her class. She completed residency in Cardiovascular Anesthesiology and Intensive Care Medicine at the Republican Scientific and Practical Center "Cardiology" in Minsk, the country's leading cardiac referral center. Her clinical work covered high-acuity cardiovascular care, from cardiogenic shock and acute coronary syndromes to perioperative management of coronary bypass, valve, and aortic surgery. In parallel, she practiced general anesthesia and critical care at Minsk Central District Clinical Hospital, including dedicated COVID-19 intensive care from March 2020 through May 2022. For her leadership during the pandemic, she received an award from the Belarusian Minister of Health, given to roughly 1 in 500 physicians nationwide.
She serves as Education Lead for iWISH Talks (Inspiring Women in Science and Healthcare), a global community of more than 500 early-career scientists, and the team received the Stanford Cardiovascular Institute Recognition Award. Outside the lab, she bakes sourdough, swims, practices Pilates, visits museums, and follows AI biology agents. -
Wenjuan Zhu
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow
